Does LEUPROLIDE Cause Testicular atrophy? 81 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Testicular atrophy have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.1% of all adverse event reports for LEUPROLIDE.
81
Reports of Testicular atrophy with LEUPROLIDE
0.1%
of all LEUPROLIDE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Testicular atrophy From LEUPROLIDE?
Of the 81 reports, 5 (6.2%) required hospitalization, and 1 (1.2%) were considered life-threatening.
Is Testicular atrophy Listed in the Official Label?
Yes, Testicular atrophy is listed as a known adverse reaction in the official FDA drug label for LEUPROLIDE.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Testicular atrophy?
FINASTERIDE (186)
TESTOSTERONE (97)
RELUGOLIX (41)
CLOZAPINE (30)
ENZALUTAMIDE (23)
ESCITALOPRAM OXALATE (20)
LORAZEPAM (20)
OLANZAPINE (20)
VENLAFAXINE (19)
CITALOPRAM HYDROBROMIDE (17)
Which LEUPROLIDE Alternatives Have Lower Testicular atrophy Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM